149 related articles for article (PubMed ID: 28877722)
21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
22. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
24. The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts.
Shaw A; Gipp J; Bushman W
Oncogene; 2009 Dec; 28(50):4480-90. PubMed ID: 19784071
[TBL] [Abstract][Full Text] [Related]
25. ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.
Zheng Y; Lin ZY; Xie JJ; Jiang FN; Chen CJ; Li JX; Zhou X; Zhong WD
Curr Mol Med; 2017; 17(3):221-229. PubMed ID: 28782483
[TBL] [Abstract][Full Text] [Related]
26. Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer.
Singh SK; Gordetsky JB; Bae S; Acosta EP; Lillard JW; Singh R
Cells; 2020 Aug; 9(9):. PubMed ID: 32867229
[TBL] [Abstract][Full Text] [Related]
27. LKB1 suppresses proliferation and invasion of prostate cancer through hedgehog signaling pathway.
Xu P; Cai F; Liu X; Guo L
Int J Clin Exp Pathol; 2014; 7(12):8480-8. PubMed ID: 25674212
[TBL] [Abstract][Full Text] [Related]
28. CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer.
Leclerc BG; Charlebois R; Chouinard G; Allard B; Pommey S; Saad F; Stagg J
Clin Cancer Res; 2016 Jan; 22(1):158-66. PubMed ID: 26253870
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog signaling in prostate growth and benign prostate hyperplasia.
Vezina CM; Bushman AW
Curr Urol Rep; 2007 Jul; 8(4):275-80. PubMed ID: 18519011
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog signaling is active in human prostate cancer stroma and regulates proliferation and differentiation of adjacent epithelium.
Wilkinson SE; Furic L; Buchanan G; Larsson O; Pedersen J; Frydenberg M; Risbridger GP; Taylor RA
Prostate; 2013 Dec; 73(16):1810-23. PubMed ID: 24105601
[TBL] [Abstract][Full Text] [Related]
32. Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
Barata PC; Magi-Galluzzi C; Gupta R; Dreicer R; Klein EA; Garcia JA
Clin Genitourin Cancer; 2019 Oct; 17(5):366-372. PubMed ID: 31262501
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer.
Ling XH; Han ZD; Xia D; He HC; Jiang FN; Lin ZY; Fu X; Deng YH; Dai QS; Cai C; Chen JH; Liang YX; Zhong WD; Wu CL
Mol Biol Rep; 2014 May; 41(5):2779-88. PubMed ID: 24452717
[TBL] [Abstract][Full Text] [Related]
35. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
[TBL] [Abstract][Full Text] [Related]
36. A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.
Leyh-Bannurah SR; Trudel D; Latour M; Zaffuto E; Grosset AA; Tam C; Ouellet V; Graefen M; Budäus L; Aprikian AG; Lacombe L; Fleshner NE; Gleave ME; Mes-Masson AM; Saad F; Karakiewicz PI
Pathol Oncol Res; 2019 Jul; 25(3):979-986. PubMed ID: 29623528
[TBL] [Abstract][Full Text] [Related]
37. Hedgehog gene expression patterns among intrinsic subtypes of breast cancer: Prognostic relevance.
García-Martínez A; Pérez-Balaguer A; Ortiz-Martínez F; Pomares-Navarro E; Sanmartín E; García-Escolano M; Montoyo-Pujol YG; Castellón-Molla E; Peiró G
Pathol Res Pract; 2021 Jul; 223():153478. PubMed ID: 34022683
[TBL] [Abstract][Full Text] [Related]
38. Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.
Zhang H; Qi C; Wang A; Yao B; Li L; Wang Y; Xu Y
J Exp Clin Cancer Res; 2013 Oct; 32(1):77. PubMed ID: 24422979
[TBL] [Abstract][Full Text] [Related]
39. Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling.
Tzelepi V; Karlou M; Wen S; Hoang A; Logothetis C; Troncoso P; Efstathiou E
Histopathology; 2011 Jun; 58(7):1037-47. PubMed ID: 21707705
[TBL] [Abstract][Full Text] [Related]
40. Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.
Ishikawa M; Sonobe M; Imamura N; Sowa T; Shikuma K; Date H
World J Surg Oncol; 2014 Aug; 12():253. PubMed ID: 25103784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
